Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination MeSH Descriptor Data 2025

MeSH Heading: Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
Tree Number(s): D02.241.081.251.203.500; D02.705.429.906.250; D02.886.675.182.500; D03.383.129.708.189.500; D03.383.742.680.245.500.600.250; D03.633.100.759.138.881.250; D13.570.230.329.525.250; D13.570.685.245.500.600.250; D26.310.391
Unique ID: D000069545
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D000069545
Scope Note: A pharmaceutical preparation of the ANTI-HIV AGENTS elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate that is used in the treatment of HIV INFECTIONS.
Entry Term(s): Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate; Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate Drug Combination; Elvitegravir-Cobicistat-Emtricitabine-Tenofovir Disoproxil Fumarate Drug Combination; Genvoya; Quad Pill; Stribild
Pharm Action: Anti-HIV Agents
Public MeSH Note: 2016; ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, TENOFOVIR DISOPROXIL FUMARATE was indexed under CARBAMATES; DEOXYCITIDINE; THIAZOLES; QUINOLONES and ORGANOPHOSPHONATES 2012-2015
History Note: 2016 (2012)
Date Established: 2016/01/01
Date of Entry: 2015/07/01
Revision Date: 2020/05/27

Allowable Qualifiers: administration & dosage (AD)

adverse effects (AE)

agonists (AG)

analysis (AN)

antagonists & inhibitors (AI)

blood (BL)

cerebrospinal fluid (CF)

chemical synthesis (CS)

chemistry (CH)

classification (CL)

economics (EC)

history (HI)

immunology (IM)

isolation & purification (IP)

metabolism (ME)

pharmacokinetics (PK)

pharmacology (PD)

poisoning (PO)

radiation effects (RE)

standards (ST)

supply & distribution (SD)

therapeutic use (TU)

toxicity (TO)

urine (UR)

Organic Chemicals [D02]
- Carboxylic Acids [D02.241]
  - Acids, Acyclic [D02.241.081]
    - Carbamates [D02.241.081.251]
      - Cobicistat [D02.241.081.251.203]
        
        Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination [D02.241.081.251.203.500]

Organic Chemicals [D02]
- Organophosphorus Compounds [D02.705]
  - Organophosphonates [D02.705.429]
    - Tenofovir [D02.705.429.906]

Organic Chemicals [D02]
- Sulfur Compounds [D02.886]
  - Thiazoles [D02.886.675]
    - Cobicistat [D02.886.675.182]
      - Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination [D02.886.675.182.500]

Heterocyclic Compounds [D03]
- Heterocyclic Compounds, 1-Ring [D03.383]
  - Azoles [D03.383.129]
    - Thiazoles [D03.383.129.708]
      - Cobicistat [D03.383.129.708.189]
        
        Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination [D03.383.129.708.189.500]

Heterocyclic Compounds [D03]
- Heterocyclic Compounds, 1-Ring [D03.383]
  - Pyrimidines [D03.383.742]
    - Pyrimidine Nucleosides [D03.383.742.680]
      - Cytidine [D03.383.742.680.245]
        
        Deoxycytidine [D03.383.742.680.245.500]
        
        Emtricitabine [D03.383.742.680.245.500.600]
        
        Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination [D03.383.742.680.245.500.600.125]
        
        Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination [D03.383.742.680.245.500.600.250]
        
        Emtricitabine, Rilpivirine, Tenofovir Drug Combination [D03.383.742.680.245.500.600.500]
        
        Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination [D03.383.742.680.245.500.600.750]

Heterocyclic Compounds [D03]
- Heterocyclic Compounds, Fused-Ring [D03.633]
  - Heterocyclic Compounds, 2-Ring [D03.633.100]
    - Purines [D03.633.100.759]
      - Adenine [D03.633.100.759.138]
        
        Tenofovir [D03.633.100.759.138.881]
        
        Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination [D03.633.100.759.138.881.125]
        
        Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination [D03.633.100.759.138.881.250]
        
        Emtricitabine, Rilpivirine, Tenofovir Drug Combination [D03.633.100.759.138.881.500]
        
        Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination [D03.633.100.759.138.881.750]

Nucleic Acids, Nucleotides, and Nucleosides [D13]
- Nucleosides [D13.570]
  - Deoxyribonucleosides [D13.570.230]
    - Deoxycytidine [D13.570.230.329]
      - Emtricitabine [D13.570.230.329.525]
        
        Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination [D13.570.230.329.525.250]
        
        Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination [D13.570.230.329.525.500]

Nucleic Acids, Nucleotides, and Nucleosides [D13]
- Nucleosides [D13.570]
  - Pyrimidine Nucleosides [D13.570.685]
    - Cytidine [D13.570.685.245]
      - Deoxycytidine [D13.570.685.245.500]
        
        Emtricitabine [D13.570.685.245.500.600]
        
        Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination [D13.570.685.245.500.600.250]
        
        Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination [D13.570.685.245.500.600.500]

Pharmaceutical Preparations [D26]
- Drug Combinations [D26.310]

Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination Preferred

Stribild Narrower

Quad Pill Narrower

Genvoya Narrower

page delivered in 0.159s